Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanMyeloablative AgonistsMultiple MyelomaTreatment OutcomeStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicImmunosuppressive AgentsVidarabineRetrospective StudiesAmyloidosisHematopoiesisSalvage TherapyLeukemiaIfosfamideSurvival RateVincristineSurvival AnalysisCarmustineBlood CellsGraft vs Leukemia EffectCytarabineHodgkin DiseaseLeukemia, Myeloid, AcutePlatelet CountTime FactorsMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticBlood Cell CountLymphomaCytophagocytosisLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionNeoplasmsFatal OutcomeLivedo ReticularisHistiocytosis, Non-Langerhans-CellFeasibility StudiesFollow-Up StudiesOpportunistic InfectionsHematologic DiseasesDoxorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineHLA AntigensBlood DonorsBone MarrowImmunophenotypingImmunosuppressionProspective StudiesRecombinant ProteinsMesenchymal Stem Cell TransplantationLymphoma, T-CellBone Marrow PurgingPilot ProjectsPrednisoneCarboplatinBone Marrow DiseasesAntigens, CDPrognosisBlood Group IncompatibilityNeoplasm, ResidualKidney TransplantationAntineoplastic Agents